PubRank

Antonio Egidio Nardi

Author PubWeight™ 44.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Psychiatric disorders in asthmatic outpatients. Psychiatry Res 2002 1.03
2 Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptoms. Neuro Oncol 2014 0.96
3 Sexual dysfunction and cardiovascular diseases: a systematic review of prevalence. Clinics (Sao Paulo) 2013 0.91
4 National Science and Technology Institute for Translational Medicine (INCT-TM): advancing the field of translational medicine and mental health. Rev Bras Psiquiatr 2010 0.91
5 The role of dietary polyphenols on adult hippocampal neurogenesis: molecular mechanisms and behavioural effects on depression and anxiety. Oxid Med Cell Longev 2012 0.91
6 Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies. Expert Rev Neurother 2010 0.87
7 Caffeine challenge test and panic disorder: a systematic literature review. Expert Rev Neurother 2011 0.87
8 Translational findings on brain-derived neurotrophic factor and anxiety: contributions from basic research to clinical practice. Neuropsychobiology 2013 0.86
9 Prevalence of psychiatric disorders in the first trimester of pregnancy and factors associated with current suicide risk. Psychiatry Res 2013 0.85
10 Factors associated with risk of suicide in patients with hemodialysis. Compr Psychiatry 2010 0.84
11 The effects of dehydroepiandrosterone (DHEA) in the treatment of depression and depressive symptoms in other psychiatric and medical illnesses: a systematic review. Curr Drug Targets 2014 0.84
12 The effectiveness of cognitive behavioral group therapy in treating bipolar disorder: a randomized controlled study. Rev Bras Psiquiatr 2011 0.84
13 Anxiety, panic disorder and coronary artery disease: issues concerning physical exercise and cognitive behavioral therapy. Expert Rev Cardiovasc Ther 2011 0.84
14 Nomophobia: the mobile phone in panic disorder with agoraphobia: reducing phobias or worsening of dependence? Cogn Behav Neurol 2010 0.84
15 Epidemiology of early-onset dementia: a review of the literature. Clin Pract Epidemiol Ment Health 2013 0.83
16 Comorbidity of depression and anxiety: association with poor quality of life in type 1 and 2 diabetic patients. Clin Pract Epidemiol Ment Health 2013 0.82
17 Virtual reality as a mechanism for exposure therapy. World J Biol Psychiatry 2010 0.82
18 Prevalence of psychiatric disorders in patients with diabetes types 1 and 2. Compr Psychiatry 2012 0.82
19 Current findings of fMRI in panic disorder: contributions for the fear neurocircuitry and CBT effects. Expert Rev Neurother 2010 0.82
20 Cognitive functions in patients with panic disorder: a literature review. Rev Bras Psiquiatr 2013 0.82
21 [Depression during pregnancy and low birth weight: a systematic literature review]. Cad Saude Publica 2010 0.82
22 Treatment of Cognitive Deficits in Alzheimer's disease: A psychopharmacological review. Psychiatr Danub 2016 0.81
23 Effects of School-Based Physical Activity Interventions on Cognition and Academic Achievement: A Systematic Review. CNS Neurol Disord Drug Targets 2015 0.80
24 Time perception impairs sensory-motor integration in Parkinson's disease. Int Arch Med 2013 0.80
25 Changes in alpha band activity associated with application of the compression of fourth ventricular (CV-4) osteopathic procedure: a qEEG pilot study. J Bodyw Mov Ther 2012 0.80
26 Efficacy of a specific model for cognitive-behavioral therapy among panic disorder patients with agoraphobia: a randomized clinical trial. Sao Paulo Med J 2011 0.79
27 Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs. Compr Psychiatry 2013 0.79
28 A review of preliminary observations on agomelatine in the treatment of anxiety disorders. Exp Clin Psychopharmacol 2012 0.79
29 Comparison of two doses of metformin (2.5 and 1.5 g/day) for the treatment of polycystic ovary syndrome and their effect on body mass index and waist circumference. Fertil Steril 2007 0.78
30 Temperament and character dimensions and their relationship to major depression and panic disorder. Rev Bras Psiquiatr 2012 0.78
31 Respiratory manifestations of panic disorder: causes, consequences and therapeutic implications. J Bras Pneumol 2009 0.78
32 Therapeutic response to benzodiazepine in panic disorder subtypes. Sao Paulo Med J 2003 0.78
33 Cross-cultural adaptation, validation and reliability of the brazilian version of the Richmond Compulsive Buying Scale. Rev Bras Psiquiatr 2013 0.78
34 Alpha absolute power measurement in panic disorder with agoraphobia patients. J Affect Disord 2013 0.78
35 The carbon dioxide challenge test in panic disorder: a systematic review of preclinical and clinical research. Rev Bras Psiquiatr 2013 0.78
36 The mirror neuron system in post-stroke rehabilitation. Int Arch Med 2013 0.77
37 [Are panic attacks really harmless? The cardiovascular impact of panic disorder]. Rev Bras Psiquiatr 2009 0.77
38 Deep brain stimulation: a new treatment in mood and anxiety disorders. CNS Neurol Disord Drug Targets 2014 0.77
39 Premotor and occipital theta asymmetries as discriminators of memory- and stimulus-guided tasks. Brain Res Bull 2011 0.77
40 Alpha-band power in the left frontal cortex discriminates the execution of fixed stimulus during saccadic eye movement. Neurosci Lett 2012 0.76
41 rTMS to treat social anxiety disorder: a case report. Rev Bras Psiquiatr 2013 0.76
42 Sex therapy for female sexual dysfunction. Int Arch Med 2013 0.76
43 Changes in saccadic eye movement (SEM) and quantitative EEG parameter in bipolar patients. J Affect Disord 2012 0.76
44 Effects of Aerobic Exercise on Anxiety Disorders: A Systematic Review. CNS Neurol Disord Drug Targets 2015 0.76
45 Brazilian Portuguese validated version of the Cardiac Anxiety Questionnaire. Arq Bras Cardiol 2013 0.76
46 Treatment of internet addiction in patient with panic disorder and obsessive compulsive disorder: a case report. CNS Neurol Disord Drug Targets 2015 0.76
47 From Mind to Body: Is Mental Practice Effective on Strength Gains? A Meta-Analysis. CNS Neurol Disord Drug Targets 2015 0.76
48 Re: Experimental affective symptoms in panic disorder patients. Can J Psychiatry 2005 0.75
49 Treatment of Internet Addiction with Anxiety Disorders: Treatment Protocol and Preliminary Before-After Results Involving Pharmacotherapy and Modified Cognitive Behavioral Therapy. JMIR Res Protoc 2016 0.75
50 Effects of Exercise on Physical and Mental Health, and Cognitive and Brain Functions in Schizophrenia: Clinical and Experimental Evidence. CNS Neurol Disord Drug Targets 2015 0.75
51 Psychiatric disorders and quality of life in patients with implantable cardioverter defibrillators: a systematic review. Prim Care Companion CNS Disord 2013 0.75
52 Current concept of anxiety: implications from Darwin to the DSM-V for the diagnosis of generalized anxiety disorder. Expert Rev Neurother 2010 0.75
53 The panic disorder respiratory ratio: a dimensional approach to the respiratory subtype. Rev Bras Psiquiatr 2013 0.75
54 Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient. Case Rep Med 2011 0.75
55 Panic attack triggering myocardial ischemia documented by myocardial perfusion imaging study. A case report. Int Arch Med 2012 0.75
56 Brazil launches an innovative program to develop the National Institutes for Science and Technology (INCTs): the INCT for Translational Medicine. Rev Bras Psiquiatr 2009 0.75
57 The quest for better diagnosis: DSM-5 or RDoC? Rev Bras Psiquiatr 2013 0.75
58 Cognitive mechanisms and motor control during a saccadic eye movement task: evidence from quantitative electroencephalography. Arq Neuropsiquiatr 2012 0.75
59 Personality Traits in Panic Disorder Patients With and Without Comorbidities. J Nerv Ment Dis 2017 0.75
60 Aerobic Exercise Does Not Predict Brain Derived Neurotrophic Factor And Cortisol Alterations in Depressed Patients. CNS Neurol Disord Drug Targets 2015 0.75
61 Carbon dioxide test as an additional clinical measure of treatment response in panic disorder. Arq Neuropsiquiatr 2002 0.75
62 Cognitive-behavioral therapy for bipolar disorder. Expert Rev Neurother 2010 0.75
63 Bilateral DMPFC-rTMS Leads to Sustained Remission in Geriatric Treatment-Resistant Depression: A Case Report. Psychiatr Danub 2017 0.75
64 Potential Therapeutic Effects of Physical Exercise for Bipolar Disorder. CNS Neurol Disord Drug Targets 2015 0.75
65 What Do Athletes Know on the Effect of Steroids? An Exploratory Study in Italy. CNS Neurol Disord Drug Targets 2015 0.75
66 Implications of movement-related cortical potential for understanding neural adaptations in muscle strength tasks. Int Arch Med 2014 0.75
67 Evoked Potential in Panic Disorder Patients: A Systematic Review. CNS Neurol Disord Drug Targets 2015 0.75
68 Public speaking in social phobia: a pilot study of self-ratings and observers' ratings of social skills. J Clin Psychol 2012 0.75
69 Neuroscience of Exercise: Association Among Neurobiological Mechanisms and Mental Health. CNS Neurol Disord Drug Targets 2015 0.75
70 Comparison Among Aerobic Exercise and Other Types of Interventions to Treat Depression: A Systematic Review. CNS Neurol Disord Drug Targets 2015 0.75
71 New therapeutic options for anxiety and mood disorders. CNS Neurol Disord Drug Targets 2014 0.75
72 Psychiatric disorders in patients with end-stage renal disease. J Ren Care 2012 0.75